Immunochemistry and immunoblotting studies of AD post-mortem brains have shown the predominantly cytoplasmic, and not nuclear, localization of Nrf2 in the hippocampal neurons and astrocytes, compared to age-mated controls [109]. Here, NFE2L2 is linked to Alzheimer disease.